DE SB45

Adds 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) to Schedule I of Delaware's Uniform Controlled Substances Act as item (59).

U-47700, also known as "Pink," is a synthetic opioid marketed as a "research chemical" over the Internet and is being abused for its opioid properties.

The Federal Drug Enforcement Agency temporarily placed U-47700 in Schedule I on November 14, 2016, for a two-year period, finding it has high potential for abuse and no accepted medical use.

Delaware's Secretary of State issued an emergency order on December 15, 2016, temporarily placing U-47700 in Schedule I for 120 days, which this bill makes permanent.

The permanent addition is intended to address significant public health and safety risks including drug treatment admissions, emergency room visits, and fatal overdoses from U-47700 abuse.